Stay updated with breaking news from Rhythm Pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shareholders might have noticed that Rhythm Pharmaceuticals, Inc. ( NASDAQ:RYTM ) filed its yearly result this time...
PRIMECAP Management (Trades, Portfolio), a notable investment firm, has recently adjusted its investment portfolio by reducing its stake in Rhythm Pharmaceuticals Inc (NASDAQ:RYTM). This move, executed on December 31, 2023, reflects the firm's ongoing portfolio management strategy and its assessment of RYTM's investment potential.
-- Phase 3 trial evaluating setmelanotide in pediatric patients ages 2-...
Several biotechs in Mass. are seeking to elbow their way into the lucrative market, which is currently dominated by Denmark’s Novo Nordisk, which makes Wegovy and Ozempic, and Eli Lilly, which produces Mounjaro.
Rhythm Pharmaceuticals, Inc. ( NASDAQ:RYTM ) shareholders will have a reason to smile today, with the analysts making...